Xynomic Pharma

xynomic pharmaceuticals, inc. is a us incorporated biopharmaceutical company founded by us-china industry veterans and successful entrepreneurs. xynomic pharma focuses on in-licensing, developing and commercializing oncology drug candidates in china, us, and rest of the world. the founding executives worked at leading multinational biopharmaceutical companies (schering, eli lilly, merck, and roche) in r&d roles. the founders also had successful entrepreneurial experiences including founding, building, and exiting successful us-china biopharmaceutical companies. xynomic pharma aims to build a comprehensive clinical and pre-clinical stage oncology pipeline targeting cancers with high prevalence in china, us and rest of the world. xynomic pharma leverages global resources, enabling the company to develop drugs in a cost and time-efficient manner. xynomic pharma is headquartered in the shanghai with major operations in us and shanghai, china.